vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $150.6M, roughly 1.5× GLAUKOS Corp). GLAUKOS Corp runs the higher net margin — 6.2% vs 4.4%, a 1.8% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 20.3%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 5.1%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

CSW vs GKOS — Head-to-Head

Bigger by revenue
CSW
CSW
1.5× larger
CSW
$233.0M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+20.8% gap
GKOS
41.2%
20.3%
CSW
Higher net margin
GKOS
GKOS
1.8% more per $
GKOS
6.2%
4.4%
CSW
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
5.1%
CSW

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CSW
CSW
GKOS
GKOS
Revenue
$233.0M
$150.6M
Net Profit
$10.3M
$9.4M
Gross Margin
39.7%
77.9%
Operating Margin
7.4%
9.0%
Net Margin
4.4%
6.2%
Revenue YoY
20.3%
41.2%
Net Profit YoY
-61.9%
EPS (diluted)
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$233.0M
$143.1M
Q3 25
$277.0M
$133.5M
Q2 25
$263.6M
$124.1M
Q1 25
$230.5M
$106.7M
Q4 24
$193.6M
$105.5M
Q3 24
$227.9M
$96.7M
Q2 24
$226.2M
$95.7M
Net Profit
CSW
CSW
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$10.3M
$-133.7M
Q3 25
$40.7M
$-16.2M
Q2 25
$40.9M
$-19.7M
Q1 25
$35.1M
$-18.1M
Q4 24
$26.9M
$-33.6M
Q3 24
$36.1M
$-21.4M
Q2 24
$38.6M
$-50.5M
Gross Margin
CSW
CSW
GKOS
GKOS
Q1 26
77.9%
Q4 25
39.7%
-1.1%
Q3 25
43.0%
78.4%
Q2 25
43.8%
78.3%
Q1 25
44.2%
77.2%
Q4 24
41.4%
72.9%
Q3 24
45.6%
76.6%
Q2 24
47.5%
76.4%
Operating Margin
CSW
CSW
GKOS
GKOS
Q1 26
9.0%
Q4 25
7.4%
-97.7%
Q3 25
20.5%
-12.3%
Q2 25
20.8%
-18.3%
Q1 25
19.5%
-19.4%
Q4 24
15.3%
-27.2%
Q3 24
22.6%
-25.5%
Q2 24
24.3%
-31.3%
Net Margin
CSW
CSW
GKOS
GKOS
Q1 26
6.2%
Q4 25
4.4%
-93.4%
Q3 25
14.7%
-12.2%
Q2 25
15.5%
-15.8%
Q1 25
15.2%
-17.0%
Q4 24
13.9%
-31.8%
Q3 24
15.8%
-22.1%
Q2 24
17.1%
-52.8%
EPS (diluted)
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
$0.62
$-2.34
Q3 25
$2.41
$-0.28
Q2 25
$2.43
$-0.34
Q1 25
$2.05
$-0.32
Q4 24
$1.60
$-0.56
Q3 24
$2.26
$-0.39
Q2 24
$2.47
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$40.2M
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$670.9M
Total Assets
$2.3B
$893.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$40.2M
$90.8M
Q3 25
$31.5M
$98.2M
Q2 25
$38.0M
$100.8M
Q1 25
$225.8M
$114.3M
Q4 24
$213.8M
$169.6M
Q3 24
$273.2M
$100.1M
Q2 24
$18.9M
$68.1M
Total Debt
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$800.1M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CSW
CSW
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$1.1B
$656.2M
Q3 25
$1.1B
$769.5M
Q2 25
$1.1B
$765.1M
Q1 25
$1.1B
$764.0M
Q4 24
$1.0B
$766.9M
Q3 24
$1.0B
$668.5M
Q2 24
$650.2M
$665.2M
Total Assets
CSW
CSW
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$2.3B
$893.5M
Q3 25
$1.5B
$999.4M
Q2 25
$1.5B
$987.0M
Q1 25
$1.4B
$966.2M
Q4 24
$1.4B
$974.8M
Q3 24
$1.4B
$926.5M
Q2 24
$1.1B
$919.7M
Debt / Equity
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.75×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
GKOS
GKOS
Operating Cash FlowLast quarter
$28.9M
Free Cash FlowOCF − Capex
$22.7M
FCF MarginFCF / Revenue
9.8%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$162.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
$28.9M
$6.8M
Q3 25
$61.8M
$-10.1M
Q2 25
$60.6M
$7.0M
Q1 25
$27.3M
$-18.5M
Q4 24
$11.6M
$507.0K
Q3 24
$66.8M
$-9.6M
Q2 24
$62.7M
$-18.4M
Free Cash Flow
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
$22.7M
$3.9M
Q3 25
$58.7M
$-11.7M
Q2 25
$57.7M
$5.8M
Q1 25
$22.8M
$-20.5M
Q4 24
$8.5M
$-1.2M
Q3 24
$61.3M
$-11.0M
Q2 24
$59.6M
$-20.5M
FCF Margin
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
9.8%
2.7%
Q3 25
21.2%
-8.8%
Q2 25
21.9%
4.7%
Q1 25
9.9%
-19.2%
Q4 24
4.4%
-1.2%
Q3 24
26.9%
-11.4%
Q2 24
26.3%
-21.4%
Capex Intensity
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
2.6%
2.0%
Q3 25
1.1%
1.2%
Q2 25
1.1%
0.9%
Q1 25
2.0%
1.8%
Q4 24
1.6%
1.6%
Q3 24
2.4%
1.5%
Q2 24
1.4%
2.2%
Cash Conversion
CSW
CSW
GKOS
GKOS
Q1 26
Q4 25
2.81×
Q3 25
1.52×
Q2 25
1.48×
Q1 25
0.78×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

GKOS
GKOS

Segment breakdown not available.

Related Comparisons